• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
Endogenex

Endogenex

Bringing New Energy to the Treatment of Type 2 Diabetes

  • ReCET
  • Patients
  • Clinical Providers
  • About Us
    • News
    • Contact
  • Clinical Studies

Clinical Studies

Living with Type 2 Diabetes? You’re not alone.

Are you or a loved one looking for a new way to help control your Type 2 Diabetes?

ReCETTM is an investigational device for Type 2 Diabetes and is being evaluated in several clinical studies.

See if you qualify.

REGENT-1 US

Location: United States

Study type: For individuals inadequately controlled on non-insulin glucose lowering medications for Type 2 Diabetes.

See if you qualify

REGENT-1 AUS

Location: Australia

Study type: For individuals inadequately controlled on non-insulin glucose lowering medications with or without insulin for Type 2 Diabetes.

See if you qualify

EMINENT Study

Location: Netherlands

Study type: For individuals with Type 2 Diabetes using insulin to control their glucose levels.

Email to see if you qualify

diabetes-onderzoek@amsterdamumc.nl

For physicians

If you are a physician or clinical provider interested in our clinical studies, please contact us.


* Caution: Exclusively a clinical investigational device. Limited by federal (or United States or similar) law to investigational use. Not for sale in any geography.

Endogenex, Inc.
151 Cheshire Ln N #400
Plymouth, MN 55441
+1 763-251-6820
info@endogenex.com

  • Facebook
  • Twitter
  • LinkedIn
  • Vimeo

References

Terms of Use

Privacy Policy

Cookie Policy

Join our mailing list


EndogenexTM and ReCETTM are registered trademarks of Endogenex, Inc. in the United States and other countries.

Copyright © 2023 Endogenex, Inc. All rights reserved.